{"id":3577,"date":"2023-02-27T15:19:01","date_gmt":"2023-02-27T14:19:01","guid":{"rendered":"https:\/\/www.access2meds.eu\/startseite\/"},"modified":"2025-06-23T11:27:11","modified_gmt":"2025-06-23T09:27:11","slug":"startseite","status":"publish","type":"page","link":"https:\/\/www.access2meds.eu\/de\/","title":{"rendered":"Startseite"},"content":{"rendered":"

[et_pb_section fb_built=“1″ admin_label=“Header“ _builder_version=“4.20.2″ _module_preset=“default“ background_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg“ background_position=“top_center“ height=“100vh“ max_height=“660px“ global_colors_info=“{}“][et_pb_row _builder_version=“4.20.0″ _module_preset=“default“ custom_padding=“7px|30px||30px|false|true“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.20.2″ _module_preset=“default“ header_font=“|700|||||||“ header_line_height=“1.1em“ custom_margin=“11px||||false|false“ global_colors_info=“{}“]<\/p>\n

INNOVATIVE GESUNDHEITSTECHNOLOGIEN <\/span>
BESSER ZUG\u00c4NGLICH MACHEN<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“first text blue pill“ _builder_version=“4.20.0″ _module_preset=“default“ background_enable_color=“off“ custom_padding=“0px||0px||false|false“ global_colors_info=“{}“][et_pb_row custom_padding_last_edited=“on|phone“ module_class=“starttoppill“ _builder_version=“4.20.2″ _module_preset=“default“ background_color=“#3b3e84″ vertical_offset=“-90px“ max_width=“1500px“ module_alignment=“right“ custom_margin=“||||false|false“ custom_padding=“60px||50px|93px|false|false“ custom_padding_tablet=“60px||50px|93px|false|false“ custom_padding_phone=“|10px||65px|false|false“ custom_css_main_element=“width:calc(100% – 125px)!important;“ border_radii=“off|99999px|||99999px“ global_colors_info=“{}“ custom_css_main_element_last_edited=“on|phone“ custom_css_main_element_phone=“width:calc(100%)!important;“ custom_css_main_element_tablet=“width:calc(100% – 125px)!important;“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.20.2″ _module_preset=“default“ text_font=“||||||||“ text_text_color=“#FFFFFF“ text_font_size=“24px“ text_line_height=“1.33em“ width=“100%“ max_width=“825px“ custom_margin_tablet=““ custom_margin_phone=“||0px||false|false“ custom_margin_last_edited=“on|phone“ custom_padding_tablet=““ custom_padding_phone=“||0px|10px|false|false“ custom_padding_last_edited=“on|phone“ text_font_size_tablet=“22px“ text_font_size_phone=“16px“ text_font_size_last_edited=“on|phone“ text_line_height_tablet=“1.33em“ text_line_height_phone=“1.2em“ text_line_height_last_edited=“on|phone“ global_colors_info=“{}“]<\/p>\n

ASCERTAIN (Affordability and Sustainability improvements through new pricing, Cost-Effectiveness and ReimbursemenT models to Appraise INnovative health technologies) widmet sich der Herausforderung, innovative Gesundheitstechnologien \u2013 einschlie\u00dflich Arzneimitteln \u2013 in Europa erschwinglicher und zug\u00e4nglicher zu machen. Dabei stehen die Bed\u00fcrfnisse von Patient:innen, \u00c4rzt:innen, Kostentr\u00e4gern, Regulierungsbeh\u00f6rden und der Industrie im Mittelpunkt.<\/p>\n

[\/et_pb_text][et_pb_button button_url=“https:\/\/www.access2meds.eu\/de\/auswirkungen\/“ button_text=“Finden Sie heraus, wie Sie davon profitieren k\u00f6nnen!“ button_alignment=“right“ module_class=“bubble-button“ _builder_version=“4.20.2″ _module_preset=“default“ custom_button=“on“ button_text_size=“24px“ button_text_color=“#FFFFFF“ button_bg_color=“RGBA(255,255,255,0)“ button_border_width=“0px“ button_font=“||||||||“ button_icon=“9||divi||400″ button_on_hover=“off“ button_text_size_tablet=“24px“ button_text_size_phone=“16px“ button_text_size_last_edited=“on|phone“ custom_css_main_element=“font-weight:500;“ custom_css_after=“border-radius: 50%;background: #e85d6b;|| width: 30px;|| height: 30px;|| text-align: center; top:10px;|| line-height: 30px !important;“ global_colors_info=“{}“ custom_css_after_last_edited=“on|phone“ custom_css_after_phone=“border-radius: 50%;background: #e85d6b;|| width: 20px;|| height: 20px;|| text-align: center; top:8px;|| line-height: 20px !important;“ custom_css_after_tablet=“border-radius: 50%;background: #e85d6b;|| width: 30px;|| height: 30px;|| text-align: center; top:10px;|| line-height: 30px !important;“][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“faq“ module_id=“ermitteln-faq“ _builder_version=“4.20.2″ _module_preset=“default“ overflow-x=“hidden“ custom_padding=“0px||0px||false|false“ global_colors_info=“{}“][et_pb_row _builder_version=“4.20.0″ _module_preset=“default“ custom_padding=“0px|30px||30px|false|true“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.20.2″ _module_preset=“default“ text_font=“|600|||||||“ text_font_size=“36px“ header_font=“|600|||||||“ header_text_align=“left“ header_text_color=“#FFFFFF“ header_font_size=“36px“ header_line_height=“75px“ background_color=“#e85d6b“ background_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg“ background_size=“custom“ background_image_width=“31px“ background_image_height=“30px“ background_position=“center_right“ background_horizontal_offset=“27px“ width=“160px“ height=“75px“ height_tablet=“75px“ height_phone=“50px“ height_last_edited=“on|phone“ custom_padding=“|86px|||false|false“ link_option_url=“https:\/\/www.access2meds.eu\/faq\/“ header_font_size_tablet=“36px“ header_font_size_phone=“24px“ header_line_height_tablet=“75px“ header_line_height_phone=“50px“ header_line_height_last_edited=“on|phone“ custom_css_main_element=“overflow:visible;“ custom_css_after=“content:%22%22; display:block; width:2000px; height:100%; background:#e85d6b; position:absolute; top:0;right:160px;“ border_radii=“off||9999px|9999px|“ global_colors_info=“{}“]<\/p>\n

FAQ<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=“4.20.0″ _module_preset=“default“ background_color=“#fbedec“ positioning=“absolute“ position_origin_a=“top_center“ vertical_offset=“408px“ max_width=“100%“ height=“675px“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_2,1_2″ _builder_version=“4.20.0″ _module_preset=“default“ custom_padding=“|30px|60px|30px|false|true“ global_colors_info=“{}“][et_pb_column type=“1_2″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_blurb title=“Was ist ASCERTAIN?“ image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-542576580_sturti-1024×683.jpg“ image_icon_width=“100%“ _builder_version=“4.20.2″ _module_preset=“4d864e31-c790-4706-8bfe-634bfca688dd“ global_colors_info=“{}“]<\/p>\n

ASCERTAIN ist ein Projekt, das den Menschen helfen soll, einen besseren Zugang zu neuen Gesundheitstechnologien wie Medikamenten, medizinischen Ger\u00e4ten und Tests zu erhalten. Im Rahmen des Projekts wird ein Tool entwickelt, das Entscheidungstr\u00e4gern hilft, die Kosten und Nutzen dieser neuen Gesundheitstechnologien zu verstehen. <\/p>\n

[\/et_pb_blurb][et_pb_blurb title=“Was ist das ASCERTAIN-Tool?“ image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1349268982-1024×683.jpg“ image_icon_width=“100%“ _builder_version=“4.20.2″ _module_preset=“4d864e31-c790-4706-8bfe-634bfca688dd“ background_color=“#393C84″ custom_margin_tablet=“||0px||false|false“ custom_margin_phone=“||0px||false|false“ custom_margin_last_edited=“on|tablet“ global_colors_info=“{}“]<\/p>\n

Das Tool wird online f\u00fcr alle zug\u00e4nglich sein und Informationen zu Kosten und Nutzen neuer Gesundheitstechnologien bereitstellen. Zudem werden auch Umweltaspekte ber\u00fccksichtigt. Um sicherzustellen, dass das Tool praxisnah, hochwertig und hilfreich ist, arbeitet das Projekt eng mit Patient:innen, der Industrie, politischen Entscheidungstr\u00e4gern und Kostentr\u00e4gern zusammen. <\/p>\n

[\/et_pb_blurb][\/et_pb_column][et_pb_column type=“1_2″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“ custom_css_main_element_last_edited=“on|tablet“ custom_css_main_element_tablet=“margin-bottom:0 !important;“ custom_css_main_element_phone=“margin-bottom:0 !important;“][et_pb_blurb title=“Weshalb ist die Bezahlbarkeit innovativer Gesundheitstechnologien eine Herausforderung?“ image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1440000552-1024×683.jpg“ _builder_version=“4.20.2″ _module_preset=“4d864e31-c790-4706-8bfe-634bfca688dd“ background_color=“#E85D6B“ custom_margin=“60px||30px||false|false“ custom_margin_tablet=“0px||30px||false|false“ custom_margin_phone=“0px||30px||false|false“ custom_margin_last_edited=“on|tablet“ global_colors_info=“{}“]<\/p>\n

F\u00fcr viele L\u00e4nder in der Europ\u00e4ischen Union ist es eine Herausforderung, sich neue Gesundheitstechnologien zu leisten, denn sie sind oft teuer und nicht jeder hat den gleichen Zugang zu ihnen. Dieses Tool hilft Entscheidungstr\u00e4gern zu verstehen, wie viel eine Technologie kosten sollte, welchen Mehrwert sie f\u00fcr Patient:innen bietet und welche Auswirkungen sie auf das Gesundheitsbudget haben k\u00f6nnte. <\/p>\n

[\/et_pb_blurb][et_pb_blurb title=“Was sind die Ziele von ASCERTAIN?“ image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1132274611_iStock_PeopleImages-1024×653.jpg“ _builder_version=“4.20.2″ _module_preset=“4d864e31-c790-4706-8bfe-634bfca688dd“ background_color=“#86B8BD“ custom_margin=“||||false|false“ global_colors_info=“{}“]<\/p>\n

Das Ziel von ASCERTAIN ist es, ein besseres Verst\u00e4ndnis f\u00fcr die Kosten und den Nutzen neuer Gesundheitstechnologien zu schaffen. Das Tool wird online frei zug\u00e4nglich sein und l\u00e4sst sich an die Bed\u00fcrfnisse einzelner L\u00e4nder anpassen. Es liefert Informationen zu Kosten, Nutzen und \u00f6kologischen Auswirkungen und f\u00f6rdert eine umweltfreundlichere Herstellung. <\/p>\n

[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ disabled_on=“on|on|on“ _builder_version=“4.27.4″ _module_preset=“default“ background_color=“rgba(134,184,189,0.3)“ background_enable_image=“off“ hover_enabled=“0″ disabled=“on“ global_colors_info=“{}“ sticky_enabled=“0″][et_pb_row _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“]<\/p>\n

M\u00d6CHTEN SIE DIESE SEITE LIEBER IN EINER ANDEREN SPRACHE LESEN?<\/h3>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_6,1_6,1_6,1_6,1_6,1_6″ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“1_6″ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][et_pb_image src=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Englisch-1.png“ title_text=“Sprechblase_Englisch“ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_image][\/et_pb_column][et_pb_column type=“1_6″ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][et_pb_image src=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Deutsch.png“ title_text=“Sprechblase_Deutsch“ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_image][\/et_pb_column][et_pb_column type=“1_6″ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][et_pb_image src=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Hrvatski.png“ title_text=“Sprechblase_Hrvatski“ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_image][\/et_pb_column][et_pb_column type=“1_6″ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][et_pb_image src=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Norsk.png“ title_text=“Sprechblase_Norsk“ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_image][\/et_pb_column][et_pb_column type=“1_6″ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][et_pb_image src=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Romana.png“ title_text=“Sprechblase_Romana“ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_image][\/et_pb_column][et_pb_column type=“1_6″ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][et_pb_image src=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_France.png“ title_text=“Sprechblase_Frankreich“ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“events“ _builder_version=“4.27.4″ _module_preset=“default“ global_colors_info=“{}“][et_pb_row _builder_version=“4.20.0″ _module_preset=“default“ custom_padding=“14px|30px|4px|30px|false|true“ locked=“off“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.25.1″ _module_preset=“default“ text_font=“|600|||||||“ text_font_size=“36px“ header_font=“|600||on|||||“ header_text_align=“left“ header_text_color=“#FFFFFF“ header_font_size=“36px“ header_line_height=“75px“ background_color=“#393C84″ background_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg“ background_size=“custom“ background_image_width=“31px“ background_image_height=“30px“ background_position=“center_right“ background_horizontal_offset=“27px“ width=“222px“ height=“75px“ height_tablet=“75px“ height_phone=“50px“ height_last_edited=“on|phone“ custom_padding=“|60px|||false|false“ link_option_url=“https:\/\/www.access2meds.eu\/de\/?page_id=3418#ascertain-events“ header_font_size_tablet=“36px“ header_font_size_phone=“24px“ header_line_height_tablet=“75px“ header_line_height_phone=“50px“ header_line_height_last_edited=“on|phone“ custom_css_main_element=“overflow:visible;“ custom_css_after=“content:%22%22; display:block; width:2000px; height:100%; background:#393c84; position:absolute; top:0;right:222px;“ border_radii=“off||9999px|9999px|“ global_colors_info=“{}“]<\/p>\n

EVENTS<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=“4.20.0″ _module_preset=“default“ max_width=“1170px“ custom_padding=“0px|0px||0px|false|true“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_code _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“]

\r\n\t
\r\n\t
\r\n\t
\r\n\t\t\t
\r\n\t\t\t\t21
-
21<\/span>\r\n\t\t\t\tOkt.<\/span>\r\n\t\t\t<\/div>\r\n\t<\/div>\r\n\t\r\n\t
\r\n\t\t
\r\n\t\t\t\r\n\t\t\r\n\t\t

ASCERTAIN Final Conference<\/a><\/h3>\r\n\r\n\t\t
\r\n\t\t\t

Join us in Brussels for our final ASCERTAIN conference.<\/p>\n\r\n\t\t\t\r\n\t\t<\/div>\r\n\t\t<\/div>\r\n\t\t

\r\n\t\t\t<\/a>\r\n\t\t\t\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t<\/div>\r\n<\/div>[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“partnerlogos“ module_id=“ascertain-news“ _builder_version=“4.20.2″ _module_preset=“default“ background_color=“#FFFFFF“ custom_padding=“0px||0px||true|false“ locked=“off“ global_colors_info=“{}“][et_pb_row _builder_version=“4.20.0″ _module_preset=“default“ positioning=“absolute“ position_origin_a=“top_center“ custom_padding=“0px|30px|0px|30px|true|true“ locked=“off“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.24.2″ _module_preset=“default“ text_font=“|600|||||||“ text_font_size=“36px“ header_font=“|600|||||||“ header_text_align=“left“ header_text_color=“#FFFFFF“ header_font_size=“36px“ header_line_height=“75px“ background_color=“#86B8BD“ background_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg“ background_size=“custom“ background_image_width=“31px“ background_image_height=“30px“ background_position=“center_right“ background_horizontal_offset=“27px“ width=“340px“ width_tablet=“340px“ width_phone=“250px“ width_last_edited=“on|phone“ height=“75px“ height_tablet=“75px“ height_phone=“50px“ height_last_edited=“on|phone“ custom_padding=“|86px|||false|false“ link_option_url=“https:\/\/www.access2meds.eu\/de\/konsortium\/“ header_font_size_tablet=“36px“ header_font_size_phone=“24px“ header_line_height_tablet=“75px“ header_line_height_phone=“50px“ header_line_height_last_edited=“on|phone“ custom_css_main_element=“overflow:visible;“ custom_css_after=“content:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;“ border_radii=“off||9999px|9999px|“ global_colors_info=“{}“]<\/p>\n

VIDEOS<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“news“ module_id=“ascertain-news“ _builder_version=“4.20.2″ _module_preset=“default“ background_color=“#E85D6B“ custom_padding=“0px||0px||true|false“ global_colors_info=“{}“][et_pb_row _builder_version=“4.20.2″ _module_preset=“default“ positioning=“absolute“ position_origin_a=“top_center“ z_index=“100″ custom_padding=“0px|30px|0px|30px|true|true“ locked=“off“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.20.2″ _module_preset=“default“ text_font=“|600|||||||“ text_font_size=“36px“ header_font=“|600||on|||||“ header_text_align=“left“ header_text_color=“#FFFFFF“ header_font_size=“36px“ header_line_height=“75px“ background_color=“#048EA3″ background_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg“ background_size=“custom“ background_image_width=“31px“ background_image_height=“30px“ background_position=“center_right“ background_horizontal_offset=“27px“ width=“190px“ height=“75px“ height_tablet=“75px“ height_phone=“50px“ height_last_edited=“on|phone“ custom_padding=“|60px|||false|false“ link_option_url=“https:\/\/www.access2meds.eu\/de\/?page_id=3418″ header_font_size_tablet=“36px“ header_font_size_phone=“24px“ header_line_height_tablet=“75px“ header_line_height_phone=“50px“ header_line_height_last_edited=“on|phone“ custom_css_main_element=“overflow:visible;“ custom_css_after=“content:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;“ border_radii=“off||9999px|9999px|“ global_colors_info=“{}“]<\/p>\n

NEWS<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=“4.20.0″ _module_preset=“default“ max_width=“100%“ module_alignment=“center“ custom_padding=“0px|0px|0px||true|false“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_dp_dmb_module_205 _builder_version=“4.20.0″ _module_preset=“default“ custom_padding=“|||30px|false|false“ global_colors_info=“{}“][\/et_pb_dp_dmb_module_205][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ _builder_version=“4.27.4″ _module_preset=“default“ background_enable_color=“off“ global_colors_info=“{}“][et_pb_row _builder_version=“4.24.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.24.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ header_2_font=“|600||on|||||“ max_width=“70%“ module_alignment=“center“ custom_margin=“||||false|false“ locked=“off“ global_colors_info=“{}“]<\/p>\n

Sehen Sie sich unsere Videos an, um mehr \u00fcber das Projekt zu erfahren<\/h2>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_3,1_3,1_3″ _builder_version=“4.24.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“1_3″ _builder_version=“4.24.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_video src=“https:\/\/www.youtube.com\/watch?v=JjYDG7BDNDE“ _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ global_colors_info=“{}“][\/et_pb_video][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ custom_margin=“||||false|false“ custom_padding=“10px||10px||false|false“ global_colors_info=“{}“]<\/p>\n

Entdecken Sie die Entstehung der sechsteiligen Serie ‚3 things about (3 Dinge \u00fcber)‘. In sechs Videos versuchen wir, komplexe Themen zug\u00e4nglicher zu machen. <\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=“1_3″ _builder_version=“4.24.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_video src=“https:\/\/www.youtube.com\/watch?v=6ZtwscRvEls“ _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ global_colors_info=“{}“][\/et_pb_video][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ custom_margin=“||||false|false“ custom_padding=“10px||10px||false|false“ global_colors_info=“{}“]<\/p>\n

\u201e3 Dinge, die Sie \u00fcber den Wert neuer Krebsmedikamente wissen sollten\u201c \u2013 Teil 6 unserer Video-Reihe!
Das Video zeigt, wie verschiedene Akteure \u2013 von Patient:innen bis zur Industrie \u2013 den Wert dieser Medikamente unterschiedlich einsch\u00e4tzen. <\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=“1_3″ _builder_version=“4.24.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_video src=“https:\/\/youtu.be\/xMF2ddO9abM“ _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ global_colors_info=“{}“][\/et_pb_video][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ custom_margin=“||||false|false“ custom_padding=“10px||10px||false|false“ global_colors_info=“{}“]<\/p>\n

\u201e3 Dinge, die Sie \u00fcber Kosteneffektivit\u00e4t wissen sollten\u201c \u2013 Teil 5 unserer Video-Reihe!
In diesem Video geht es um die Kosten-Wirksamkeits-Analyse \u2013 ein zentrales Instrument, um zu beurteilen, ob eine Behandlung nicht nur wirkt, sondern sich auch lohnt. <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_3,1_3,1_3″ _builder_version=“4.24.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“1_3″ _builder_version=“4.24.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_video src=“https:\/\/youtu.be\/e36OtJA90Qg“ _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ global_colors_info=“{}“][\/et_pb_video][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ custom_margin=“||||false|false“ custom_padding=“10px||10px||false|false“ global_colors_info=“{}“]<\/p>\n

\u201e3 Dinge, die Sie \u00fcber Kostenerstattung wissen sollten\u201c \u2013 Teil 4 unserer Video-Reihe!
In diesem Video werfen wir einen Blick auf die komplexe Welt der Arzneimittel-Erstattung \u2013 ein entscheidender Faktor daf\u00fcr, ob Patienten Zugang zu neuen Therapien erhalten. <\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=“1_3″ _builder_version=“4.24.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_video src=“https:\/\/www.youtube.com\/watch?v=6ZtwscRvEls“ _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ global_colors_info=“{}“][\/et_pb_video][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ custom_margin=“||||false|false“ custom_padding=“10px||10px||false|false“ global_colors_info=“{}“]<\/p>\n

\u201e3 Dinge, die Sie \u00fcber die Preisgestaltung neuer Medikamente wissen sollten\u201c \u2013 Teil 3 unserer Video-Reihe!
In diesem Video beleuchten wir, welche Faktoren den Preis neuer Medikamente bestimmen \u2013 ein zentrales Thema, wenn es um bezahlbare Gesundheitsversorgung geht. <\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=“1_3″ _builder_version=“4.24.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_video src=“https:\/\/www.youtube.com\/watch?v=OlmiWOpy6IA&t=2s“ _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ global_colors_info=“{}“][\/et_pb_video][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ custom_margin=“||||false|false“ custom_padding=“10px||10px||false|false“ global_colors_info=“{}“]<\/p>\n

\u201e3 Dinge, die Sie \u00fcber gestaffelte Preise wissen sollten\u201c \u2013 Teil 2 unserer Video-Reihe!
In diesem Video erkl\u00e4ren wir das Prinzip der Preisstaffelung \u2013 eine Strategie, mit der Arzneimittelpreise je nach Land oder Patientengruppe unterschiedlich festgelegt werden. <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_3,1_3,1_3″ _builder_version=“4.24.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“1_3″ _builder_version=“4.24.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_video src=“https:\/\/youtu.be\/8NhuaohK_Qg“ _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ global_colors_info=“{}“][\/et_pb_video][et_pb_text _builder_version=“4.24.2″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ custom_margin=“||||false|false“ custom_padding=“10px||10px||false|false“ global_colors_info=“{}“]<\/p>\n

\u201e3 Dinge, die Sie \u00fcber den Marktzugang wissen sollten\u201c \u2013 Teil 1 unserer Video-Reihe!
In diesem Video widmen wir uns dem zentralen Konzept des Marktzugangs \u2013 einem entscheidenden Schritt, damit neue Medikamente und Therapien f\u00fcr Patient:innen verf\u00fcgbar werden. <\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=“1_3″ _builder_version=“4.24.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_video src=“https:\/\/www.youtube.com\/watch?v=fvjJ4-2nOxk“ _builder_version=“4.24.2″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ global_colors_info=“{}“][\/et_pb_video][et_pb_text _builder_version=“4.24.2″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ custom_margin=“||||false|false“ custom_padding=“10px||10px||false|false“ global_colors_info=“{}“]<\/p>\n

Entdecken Sie in unserem Animationsvideo, wie ASCERTAIN die Ungleichheiten beim Zugang zu Gesundheitstechnologien ver\u00e4ndern m\u00f6chte! Erfahren Sie mehr \u00fcber die Ziele des Projekts. <\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=“1_3″ _builder_version=“4.24.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_video src=“https:\/\/youtu.be\/sbPnTmX8Uxs“ _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ global_colors_info=“{}“][\/et_pb_video][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ max_width=“70%“ module_alignment=“center“ custom_margin=“||||false|false“ custom_padding=“10px||10px||false|false“ global_colors_info=“{}“]<\/p>\n

Wir freuen uns, Ihnen unser Video zum Start des ASCERTAIN-Projekts in Rotterdam pr\u00e4sentieren zu k\u00f6nnen! Unsere Konsortialmitglieder kamen dort zusammen, um den offiziellen Auftakt f\u00fcr dieses von HORIZON gef\u00f6rderte Projekt zu feiern. <\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ module_id=“Kontakt“ _builder_version=“4.20.2″ _module_preset=“default“ background_color=“#86B8BD“ custom_margin=“||||false|false“ custom_padding=“16px||75px||false|false“ box_shadow_style=“preset7″ box_shadow_horizontal=“0px“ box_shadow_vertical=“-274px“ box_shadow_color=“#FFFFFF“ saved_tabs=“all“ global_colors_info=“{}“][et_pb_row _builder_version=“4.20.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.2″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.20.2″ _module_preset=“default“ header_font=“Poppins semibold|||on|||||“ header_font_size=“36px“ custom_margin=“14px||23px||false|false“ custom_margin_tablet=““ custom_margin_phone=“||30px||false|false“ custom_margin_last_edited=“on|phone“ header_font_size_phone=“24px“ global_colors_info=“{}“]<\/p>\n

Kontakt<\/h1>\n

[\/et_pb_text][et_pb_text _builder_version=“4.20.2″ _module_preset=“default“ text_font=“Poppins regular||||||||“ text_text_color=“#393C84″ text_font_size=“24px“ text_line_height=“1.33em“ module_alignment=“right“ custom_margin=“||0px||false|false“ text_font_size_tablet=““ text_font_size_phone=“18px“ text_font_size_last_edited=“on|phone“ global_colors_info=“{}“]<\/p>\n

Bitte nehmen Sie mit uns Kontakt auf, wenn Sie Fragen oder Anmerkungen haben! Wir werden uns so schnell wie m\u00f6glich bei Ihnen melden. <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=“1_3,1_3,1_3″ use_custom_gutter=“on“ module_class=“tablet-three-cols“ _builder_version=“4.20.2″ _module_preset=“default“ max_width_tablet=“980px“ max_width_phone=“500px“ max_width_last_edited=“on|phone“ custom_padding=“0px|30px|0px|30px|false|true“ global_colors_info=“{}“ custom_css_main_element_last_edited=“on|phone“ custom_css_main_element_tablet=“display:flex;“ custom_css_main_element_phone=“display:flex; flex-direction:column;“][et_pb_column type=“1_3″ _builder_version=“4.20.2″ _module_preset=“be0fba28-f74a-4ba0-9a8d-9cd30aca805d“ global_colors_info=“{}“ custom_css_main_element_last_edited=“on|tablet“ custom_css_main_element_tablet=“margin-bottom:0;“ custom_css_main_element_phone=“margin-bottom:20px;“][et_pb_image src=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Carin_Uyl-de-Groot.png“ title_text=“Carin_Uyl-de-Groot“ _builder_version=“4.20.2″ _module_preset=“a348f9e0-d57b-4c22-b522-c52b784fe57f“ global_colors_info=“{}“][\/et_pb_image][et_pb_text _builder_version=“4.20.2″ _module_preset=“default“ text_text_color=“#FFFFFF“ link_text_color=“#FFFFFF“ global_colors_info=“{}“]<\/p>\n

F\u00fcr forschungsbezogene Fragen:<\/p>\n

Carin Uyl-de Groot<\/strong>
Projektkoordinatorin<\/p>\n

Erasmus Universit\u00e4t Rotterdam
uyl@eshpm.eur.nl<\/a>
Telefon: +31 10 4081583<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=“1_3″ _builder_version=“4.20.2″ _module_preset=“be0fba28-f74a-4ba0-9a8d-9cd30aca805d“ background_color=“#393C84″ global_colors_info=“{}“ custom_css_main_element_last_edited=“on|phone“ custom_css_main_element_tablet=“margin-bottom:0;“ custom_css_main_element_phone=“margin-bottom:20px;“][et_pb_image src=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Marcel-Langone-1.png“ title_text=“Marcel-Langone“ align=“center“ _builder_version=“4.20.2″ _module_preset=“a348f9e0-d57b-4c22-b522-c52b784fe57f“ global_colors_info=“{}“][\/et_pb_image][et_pb_text _builder_version=“4.20.2″ _module_preset=“default“ text_text_color=“#FFFFFF“ link_text_color=“#FFFFFF“ global_colors_info=“{}“]<\/p>\n

F\u00fcr allgemeine Fragen zum Projekt:<\/p>\n

Marcel Langone Marques<\/strong>
Projektleiter<\/p>\n

Erasmus Universit\u00e4t Rotterdam
marcel.langonemarques@eur.nl<\/a>
Telefon: +31 10 4081583<\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=“1_3″ _builder_version=“4.20.2″ _module_preset=“be0fba28-f74a-4ba0-9a8d-9cd30aca805d“ background_color=“#048EA3″ global_colors_info=“{}“][et_pb_image src=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/06\/My-project-1-7.png“ title_text=“Mein Projekt-1 (7)“ _builder_version=“4.21.0″ _module_preset=“a348f9e0-d57b-4c22-b522-c52b784fe57f“ global_colors_info=“{}“][\/et_pb_image][et_pb_text _builder_version=“4.20.2″ _module_preset=“default“ text_text_color=“#FFFFFF“ link_text_color=“#FFFFFF“ global_colors_info=“{}“]<\/p>\n

F\u00fcr die Kommunikation:<\/p>\n

Lena Jessen<\/strong>
Projektleiter<\/p>\n

OptiMedis
l.jessen@optimedis.de<\/a>
Telefon: +49 40 226211490<\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=“1″ admin_label=“partnerlogos“ module_id=“ascertain-news“ _builder_version=“4.20.2″ _module_preset=“default“ background_color=“#FFFFFF“ custom_padding=“0px||0px||true|false“ locked=“off“ global_colors_info=“{}“][et_pb_row _builder_version=“4.20.0″ _module_preset=“default“ positioning=“absolute“ position_origin_a=“top_center“ custom_padding=“0px|30px|0px|30px|true|true“ locked=“off“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_text _builder_version=“4.27.4″ _module_preset=“default“ text_font=“|600|||||||“ text_font_size=“36px“ header_font=“|600|||||||“ header_text_align=“left“ header_text_color=“#FFFFFF“ header_font_size=“36px“ header_line_height=“75px“ background_color=“#048EA3″ background_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg“ background_size=“custom“ background_image_width=“31px“ background_image_height=“30px“ background_position=“center_right“ background_horizontal_offset=“27px“ width=“340px“ width_tablet=“340px“ width_phone=“250px“ width_last_edited=“on|phone“ height=“75px“ height_tablet=“75px“ height_phone=“50px“ height_last_edited=“on|phone“ custom_padding=“|86px|||false|false“ link_option_url=“https:\/\/www.access2meds.eu\/de\/konsortium\/“ hover_enabled=“0″ header_font_size_tablet=“36px“ header_font_size_phone=“24px“ header_line_height_tablet=“75px“ header_line_height_phone=“50px“ header_line_height_last_edited=“on|phone“ custom_css_main_element=“overflow:visible;“ custom_css_after=“content:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;“ border_radii=“off||9999px|9999px|“ global_colors_info=“{}“ sticky_enabled=“0″]<\/p>\n

Partner<\/h1>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=“4.20.2″ _module_preset=“default“ module_alignment=“center“ custom_padding=“90px|30px|0px|30px|false|true“ global_colors_info=“{}“][et_pb_column type=“4_4″ _builder_version=“4.20.0″ _module_preset=“default“ global_colors_info=“{}“][et_pb_dp_oc_custom show_arrow=“off“ show_control=“off“ thumbnail_size=“medium_large“ number_thumb=“4″ number_thumb_tablet=“4″ number_thumb_phone=“2″ number_thumb_last_edited=“on|phone“ item_margin=“20″ _builder_version=“4.27.0″ _module_preset=“default“ custom_padding=“30px||135px||false|false“ global_colors_info=“{}“][et_pb_dp_oc_custom_item upload_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Chino.io-logo-1.png“ url=“https:\/\/www.access2meds.eu\/consortium\/team-members-chino-srl\/“ admin_title=“CINO.IO“ _builder_version=“4.20.2″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/EUR-endorsement_01_RGB_2400_colour.png“ url=“https:\/\/www.access2meds.eu\/consortium\/team-members-erasmus-universiteit-rotterdam\/“ admin_title=“EUR“ _builder_version=“4.20.2″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/MPE-Logo-1.png“ url=“https:\/\/www.access2meds.eu\/consortium\/team-members-myeloma-patients-europe-aisbl\/“ admin_title=“MP“ _builder_version=“4.20.2″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Comenius_University_Bratislava-1.svg“ url=“https:\/\/www.access2meds.eu\/consortium\/team-members-comenius-university-bratislava\/“ admin_title=“CUB“ _builder_version=“4.20.2″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/R.png“ url=“https:\/\/www.access2meds.eu\/consortium\/team-members-universitetet-i-oslo\/“ admin_title=“UiO“ _builder_version=“4.20.2″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/LogoNuromedia-1.png“ url=“https:\/\/www.access2meds.eu\/consortium\/team-members-nuromedia-gmbh\/“ admin_title=“Nuromedia“ _builder_version=“4.20.2″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/06\/wortbildmarke-goeg-RGB.png“ url=“https:\/\/www.access2meds.eu\/consortium\/team-members-gesundheit-osterreich-gmbh\/“ admin_title=“G\u00d6“ _builder_version=“4.25.2″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/08\/Logo-EHA-Black.png“ url=“https:\/\/www.access2meds.eu\/consortium\/team-members-european-hematology-association\/“ admin_title=“EHA“ _builder_version=“4.27.0″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/AIM-LOGO_png24-1.png“ url=“https:\/\/www.access2meds.eu\/consortium\/team-members-association-internationale-de-la-mutualite-aim\/“ admin_title=“AIM“ _builder_version=“4.20.2″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=“https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/OptiMedis_RGB.svg“ url=“https:\/\/www.access2meds.eu\/consortium\/team-members-optimedis-ag\/“ admin_title=“optimedis“ _builder_version=“4.20.2″ _module_preset=“default“ global_colors_info=“{}“][\/et_pb_dp_oc_custom_item][\/et_pb_dp_oc_custom][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

ASCERTAIN setzt sich f\u00fcr das Bed\u00fcrfnis von Patienten, \u00c4rzten, Kostentr\u00e4gern, Regulierungsbeh\u00f6rden und Herstellern ein, die Erschwinglichkeit und Zug\u00e4nglichkeit innovativer Gesundheitstechnologien (einschlie\u00dflich Pharmazeutika) in Europa zu verbessern.<\/p>\n","protected":false},"author":1,"featured_media":2544,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-3577","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"\nASCERTAIN - VERBESSERUNG DES ZUGANGS ZU INNOVATIVEN GESUNDHEITSTECHNOLOGIEN<\/title>\n<meta name=\"description\" content=\"ASCERTAIN setzt sich f\u00fcr das Bed\u00fcrfnis von Patienten, \u00c4rzten, Kostentr\u00e4gern, Regulierungsbeh\u00f6rden und Herstellern ein, die Erschwinglichkeit und Zug\u00e4nglichkeit innovativer Gesundheitstechnologien (einschlie\u00dflich Pharmazeutika) in Europa zu verbessern.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.access2meds.eu\/de\/startseite\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ERMITTELN - DEN ZUGANG ZU INNOVATIVEN GESUNDHEITSTECHNOLOGIEN VERBESSERN\" \/>\n<meta property=\"og:description\" content=\"ASCERTAIN setzt sich f\u00fcr das Bed\u00fcrfnis von Patienten, \u00c4rzten, Kostentr\u00e4gern, Regulierungsbeh\u00f6rden und Herstellern ein, die Erschwinglichkeit und Zug\u00e4nglichkeit innovativer Gesundheitstechnologien (einschlie\u00dflich Pharmazeutika) in Europa zu verbessern.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.access2meds.eu\/de\/startseite\/\" \/>\n<meta property=\"og:site_name\" content=\"ASCERTAIN\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-23T09:27:11+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"ERMITTELN - DEN ZUGANG ZU INNOVATIVEN GESUNDHEITSTECHNOLOGIEN VERBESSERN\" \/>\n<meta name=\"twitter:description\" content=\"ASCERTAIN setzt sich f\u00fcr das Bed\u00fcrfnis von Patienten, \u00c4rzten, Kostentr\u00e4gern, Regulierungsbeh\u00f6rden und Herstellern ein, die Erschwinglichkeit und Zug\u00e4nglichkeit innovativer Gesundheitstechnologien (einschlie\u00dflich Pharmazeutika) in Europa zu verbessern.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png\" \/>\n<meta name=\"twitter:site\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"25\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/de\\\/startseite\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/de\\\/startseite\\\/\",\"name\":\"ASCERTAIN - VERBESSERUNG DES ZUGANGS ZU INNOVATIVEN GESUNDHEITSTECHNOLOGIEN\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/de\\\/startseite\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/de\\\/startseite\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"datePublished\":\"2023-02-27T14:19:01+00:00\",\"dateModified\":\"2025-06-23T09:27:11+00:00\",\"description\":\"ASCERTAIN setzt sich f\u00fcr das Bed\u00fcrfnis von Patienten, \u00c4rzten, Kostentr\u00e4gern, Regulierungsbeh\u00f6rden und Herstellern ein, die Erschwinglichkeit und Zug\u00e4nglichkeit innovativer Gesundheitstechnologien (einschlie\u00dflich Pharmazeutika) in Europa zu verbessern.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/de\\\/startseite\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.access2meds.eu\\\/de\\\/startseite\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/de\\\/startseite\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"width\":1900,\"height\":1267},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/de\\\/startseite\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.access2meds.eu\\\/de\\\/startseite\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Startseite\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"name\":\"ASCERTAIN\",\"description\":\"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.access2meds.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\",\"name\":\"ASCERTAIN\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ASCERTAIN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/ASCERTAIN_EU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ascertain-eu\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@ascertainproject\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ASCERTAIN - VERBESSERUNG DES ZUGANGS ZU INNOVATIVEN GESUNDHEITSTECHNOLOGIEN","description":"ASCERTAIN setzt sich f\u00fcr das Bed\u00fcrfnis von Patienten, \u00c4rzten, Kostentr\u00e4gern, Regulierungsbeh\u00f6rden und Herstellern ein, die Erschwinglichkeit und Zug\u00e4nglichkeit innovativer Gesundheitstechnologien (einschlie\u00dflich Pharmazeutika) in Europa zu verbessern.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.access2meds.eu\/de\/startseite\/","og_locale":"de_DE","og_type":"article","og_title":"ERMITTELN - DEN ZUGANG ZU INNOVATIVEN GESUNDHEITSTECHNOLOGIEN VERBESSERN","og_description":"ASCERTAIN setzt sich f\u00fcr das Bed\u00fcrfnis von Patienten, \u00c4rzten, Kostentr\u00e4gern, Regulierungsbeh\u00f6rden und Herstellern ein, die Erschwinglichkeit und Zug\u00e4nglichkeit innovativer Gesundheitstechnologien (einschlie\u00dflich Pharmazeutika) in Europa zu verbessern.","og_url":"https:\/\/www.access2meds.eu\/de\/startseite\/","og_site_name":"ASCERTAIN","article_modified_time":"2025-06-23T09:27:11+00:00","og_image":[{"url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"ERMITTELN - DEN ZUGANG ZU INNOVATIVEN GESUNDHEITSTECHNOLOGIEN VERBESSERN","twitter_description":"ASCERTAIN setzt sich f\u00fcr das Bed\u00fcrfnis von Patienten, \u00c4rzten, Kostentr\u00e4gern, Regulierungsbeh\u00f6rden und Herstellern ein, die Erschwinglichkeit und Zug\u00e4nglichkeit innovativer Gesundheitstechnologien (einschlie\u00dflich Pharmazeutika) in Europa zu verbessern.","twitter_image":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png","twitter_site":"@ASCERTAIN_EU","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"25\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.access2meds.eu\/de\/startseite\/","url":"https:\/\/www.access2meds.eu\/de\/startseite\/","name":"ASCERTAIN - VERBESSERUNG DES ZUGANGS ZU INNOVATIVEN GESUNDHEITSTECHNOLOGIEN","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.access2meds.eu\/de\/startseite\/#primaryimage"},"image":{"@id":"https:\/\/www.access2meds.eu\/de\/startseite\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","datePublished":"2023-02-27T14:19:01+00:00","dateModified":"2025-06-23T09:27:11+00:00","description":"ASCERTAIN setzt sich f\u00fcr das Bed\u00fcrfnis von Patienten, \u00c4rzten, Kostentr\u00e4gern, Regulierungsbeh\u00f6rden und Herstellern ein, die Erschwinglichkeit und Zug\u00e4nglichkeit innovativer Gesundheitstechnologien (einschlie\u00dflich Pharmazeutika) in Europa zu verbessern.","breadcrumb":{"@id":"https:\/\/www.access2meds.eu\/de\/startseite\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.access2meds.eu\/de\/startseite\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.access2meds.eu\/de\/startseite\/#primaryimage","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","width":1900,"height":1267},{"@type":"BreadcrumbList","@id":"https:\/\/www.access2meds.eu\/de\/startseite\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.access2meds.eu\/de\/startseite\/"},{"@type":"ListItem","position":2,"name":"Startseite"}]},{"@type":"WebSite","@id":"https:\/\/www.access2meds.eu\/#website","url":"https:\/\/www.access2meds.eu\/","name":"ASCERTAIN","description":"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES","publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.access2meds.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/www.access2meds.eu\/#organization","name":"ASCERTAIN","url":"https:\/\/www.access2meds.eu\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","width":1,"height":1,"caption":"ASCERTAIN"},"image":{"@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ASCERTAIN_EU","https:\/\/www.linkedin.com\/company\/ascertain-eu\/","https:\/\/www.youtube.com\/@ascertainproject"]}]}},"_links":{"self":[{"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/pages\/3577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/comments?post=3577"}],"version-history":[{"count":11,"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/pages\/3577\/revisions"}],"predecessor-version":[{"id":4361,"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/pages\/3577\/revisions\/4361"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/media\/2544"}],"wp:attachment":[{"href":"https:\/\/www.access2meds.eu\/de\/wp-json\/wp\/v2\/media?parent=3577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}